Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis

Published:2016-09-06 Issue:5 Volume:97 Page:416-429
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Ramsenthaler Christina¹²,Kane Pauline¹,Gao Wei¹,Siegert Richard J.¹³,Edmonds Polly M.⁴,Schey Stephen A.⁵,Higginson Irene J.¹

Affiliation:

1. Department of Palliative Care, Policy and Rehabilitation; Cicely Saunders Institute; Faculty of Life Sciences and Medicine; King's College London; London UK

2. Department of Palliative Medicine; Munich University Hospital; Munich Germany

3. Department of Psychology; Faculty of Health and Environmental Sciences; Auckland University of Technology; Auckland New Zealand

4. Department of Palliative Care; King's College Hospital NHS Foundation Trust; London UK

5. Department of Haematological Medicine; King's College Hospital NHS Foundation Trust; London UK

Funder

Myeloma UK

St Christopher's Hospice London

National Institute for Health Research

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12790/fullpdf

Reference75 articles.

1. Haematological Malignancy Research Network (HMRN) Epidemiology & cancer statistics group. Statistics - individual disorders. Multiple myeloma 2016 https://www.hmrn.org/statistics/disorders/24

2. Ferlay J Soerjomataram I Ervik M Dikshit R Eser S Mathers C Rebelo M Parkin DM Forman D Bray F GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 2013 http://globocan.iarc.fr

3. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008

4. Pomalidomide and low-dose dexamethasone improves health-related quality of life and prolongs time to worsening in relapsed/refractory patients with multiple myeloma enrolled in the MM-003 randomized phase III trial;Weisel;Clin Lymphoma Myeloma Leuk,2015

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review;Blood Cancer Journal;2024-02-02

2. Pain management in patients with multiple myeloma;Douleurs : Évaluation - Diagnostic - Traitement;2024-02

3. Descriptive Characteristics of Multiple Myeloma Patients in King Abdulaziz Medical City National Guard;Cureus;2024-01-21

4. Nutrition and Lifestyle-Related Factors as Predictors of Muscle Atrophy in Hematological Cancer Patients;Nutrients;2024-01-18

5. Real‐world treatment patterns in patients initiating third‐line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain;European Journal of Haematology;2023-12-25